PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22108589-5 2012 Analysis of DNA fragmentation and chromatin condensation showed that arecoline induced apoptosis of BCC-1/KMC cells in a dose-dependent manner, activated caspase-3, and decreased expression of the anti-apoptotic protein Bcl-2. Arecoline 69-78 BCL2 apoptosis regulator Homo sapiens 220-225 29931964-2 2016 METHODS: Human breast cancer MCF-7 cells were treated with arecoline at the concentrations of 0,10,30,50, 100,300,500mumol/L, the cell proliferation were detected by MTT assay, cell apoptosis were analyzed by Hoechst 33342 staining and flow cy-tometry, the protein expression of Bax,Bcl-2 and P53 were detected by Western blot. Arecoline 59-68 BCL2 apoptosis regulator Homo sapiens 283-288 29931964-4 2016 However, high concentration(100,300,500mumol/L) arecoline inhibited proliferation and induced apoptosis of MCF-7 cells in a concentration-dependent manner, arecoline also significantly increased P53 and Bax protein expression and decreased Bcl-2 protein expression. Arecoline 48-57 BCL2 apoptosis regulator Homo sapiens 240-245 29931964-4 2016 However, high concentration(100,300,500mumol/L) arecoline inhibited proliferation and induced apoptosis of MCF-7 cells in a concentration-dependent manner, arecoline also significantly increased P53 and Bax protein expression and decreased Bcl-2 protein expression. Arecoline 156-165 BCL2 apoptosis regulator Homo sapiens 240-245 29931964-5 2016 CONCLUSIONS: High concentration arecoline inhibited the proliferation and induced the apoptosis of MCF-7 cells, the mechanism was probably corrected with increasing P53 and Bax protein expression and decreasing Bcl-2 pro-tein expression. Arecoline 32-41 BCL2 apoptosis regulator Homo sapiens 211-216